| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 61.763 | 66.991 | 70.758 | 81.733 | 103.393 | 126.099 | 134.230 | 147.384 | 212.784 | 270.152 |
| Total Income - EUR | 61.834 | 67.870 | 71.301 | 82.280 | 103.431 | 131.278 | 135.255 | 147.668 | 212.793 | 274.669 |
| Total Expenses - EUR | 43.406 | 49.484 | 45.393 | 47.279 | 52.350 | 53.689 | 52.244 | 59.733 | 64.499 | 115.146 |
| Gross Profit/Loss - EUR | 18.429 | 18.386 | 25.908 | 35.001 | 51.081 | 77.589 | 83.010 | 87.935 | 148.293 | 159.523 |
| Net Profit/Loss - EUR | 16.573 | 17.707 | 25.206 | 34.178 | 50.047 | 76.430 | 81.695 | 86.494 | 146.314 | 151.985 |
| Employees | 6 | 6 | 5 | 6 | 6 | 5 | 6 | 5 | 5 | 6 |
Check the financial reports for the company - Amves Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 23.351 | 15.738 | 11.767 | 9.447 | 7.215 | 5.779 | 3.573 | 1.369 | 33.071 | 41.873 |
| Current Assets | 41.088 | 26.429 | 28.666 | 65.119 | 53.397 | 87.764 | 89.001 | 96.471 | 126.706 | 125.252 |
| Inventories | 0 | 0 | 0 | 63 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 4.851 | 7.243 | 8.419 | 7.734 | 11.095 | 14.168 | 11.703 | 16.961 | 41.232 | 22.341 |
| Cash | 22.739 | 19.186 | 20.248 | 57.321 | 42.302 | 73.596 | 36.867 | 40.336 | 37.055 | 42.601 |
| Shareholders Funds | 57.061 | 41.371 | 40.702 | 74.132 | 58.898 | 85.114 | 90.186 | 95.011 | 154.916 | 160.688 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 11.233 | 4.145 | 3.316 | 4.130 | 3.505 | 9.610 | 3.574 | 3.782 | 6.105 | 7.538 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Amves Med S.r.l.